Albuterol sulfate inhalation solution
Pro Research Analysisby 
Searched over 200M research papers
Albuterol Sulfate Inhalation Solution: Efficacy, Safety, and Comparative Studies
Introduction to Albuterol Sulfate Inhalation Solution
Albuterol sulfate is a widely used bronchodilator for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is commonly administered via inhalation solutions, metered-dose inhalers (MDIs), and dry powder inhalers (DPIs). This article synthesizes recent research on the efficacy, safety, and comparative effectiveness of albuterol sulfate inhalation solutions.
Efficacy of Albuterol Sulfate in COPD and Asthma
COPD Treatment with Albuterol and Ipratropium Bromide
A study comparing the combination of ipratropium bromide (IB) and albuterol sulfate (ALB) with each component alone in COPD patients found that the combination therapy provided superior bronchodilation. The study involved 652 patients over 85 days and demonstrated that the combination therapy significantly improved spirometric response and evening peak expiratory flow rate (PEFR) without increasing adverse events .
Albuterol Sulfate in Acute Asthma
Research on the use of albuterol sulfate in acute asthma has shown that combining it with other medications can enhance its efficacy. For instance, a study involving 78 patients with acute asthma found that adding budesonide to albuterol sulfate inhalation significantly shortened the duration of symptoms and improved clinical outcomes compared to albuterol alone . Another study with elderly patients demonstrated that combining albuterol sulfate with theophylline tablets resulted in better clinical responses and improved forced expiratory volume (FEV1) compared to albuterol alone .
Comparative Studies of Albuterol Delivery Methods
Metered-Dose Inhalers (MDIs) vs. Dry Powder Inhalers (DPIs)
Several studies have compared the efficacy and safety of albuterol delivered via MDIs and DPIs. One study found that albuterol delivered by a novel dry powder inhaler (DPI) was as effective as the traditional Ventolin MDI in terms of bronchodilation, with no significant differences in safety profiles . Another study comparing HFA-134a albuterol sulfate (a non-CFC propellant) with conventional CFC albuterol found no significant differences in bronchodilation efficacy or safety, supporting the use of HFA-134a as a viable alternative .
Long-Term Efficacy and Safety
A 12-week study comparing the Spiros DPI and Ventolin MDI in patients with mild to moderate asthma found that both delivery methods were equally effective in improving FEV1 parameters. Both treatments were superior to placebo, and no significant differences in adverse events were observed between the two active treatment groups . Another study confirmed the therapeutic comparability of albuterol delivered via a breath-actuated inhaler (Spiros) and a conventional MDI, with similar effects on lung function and safety parameters .
Analytical Methods for Albuterol Sulfate
An isocratic reversed-phase high-performance liquid chromatographic (RP-HPLC) method has been developed for determining albuterol sulfate and its related substances in inhalation solutions. This method is precise, accurate, and capable of resolving multiple albuterol-related impurities, ensuring the quality and stability of the inhalation solution .
Conclusion
Albuterol sulfate inhalation solutions are effective in treating respiratory conditions such as COPD and asthma. Combination therapies with other medications like ipratropium bromide and budesonide can enhance its efficacy. Comparative studies indicate that albuterol delivered via MDIs and DPIs are equally effective and safe. Advanced analytical methods ensure the quality and stability of albuterol sulfate inhalation solutions, supporting their widespread clinical use.
Sources and full results
Most relevant research papers on this topic
The Clinical Efficacy Observation about Budesonide Suspension with Albuterol Sulfate Solution by Inhalation to Treat Bronchiolitis
Budesonide suspension combined with albuterol sulfate solution by inhalation significantly improves symptoms and shortens hospitalization duration in children with bronchiolitis.
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials
AS MDI 180 g is an equivalent dose to Proventil for bronchodilation in patients with asthma, supporting its selection for Phase III clinical trials.
Clinical Observation of Aerosol Inhalation of Albuterol Sulfate and Budesonide in the Treatment of Acute Asthma
Aerosol inhalation of albuterol sulfate and budesonide effectively improves symptoms and shortens the duration of acute asthma treatment without adverse drug reactions.
Curative effect of albuterol sulfate aerosol inhalation and theophylline tablets among elderly patients with acute asthma
Albuterol sulfate aerosol inhalation combined with theophylline tablets effectively treats acute senile asthma with better safety and convenience compared to monotherapy.
Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
The dry powder inhaler safely and effectively delivered albuterol sulfate powder (Rotacaps) into human lungs with bronchodilation, compared to the metered-dose inhaler and conventional inhalers.
DOI
Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
HFA-134a albuterol sulfate provides bronchodilation comparable to CFC albuterol and has a similar safety profile in patients with asthma.
DOI
Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma.
The breath-actuated inhaler (Spiros) is therapeutically comparable to the conventional metered dose inhaler (Ventolin) for providing one and two actuations of albuterol in patients with mild-to-moderate asthma.
DOI